BDO quits role supporting family accused of international scam empire and five key races to watch in US elections ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a major consumer health goods company if shareholders approve.

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...

A price-sensitive, value-conscious consumer adds a degree of unevenness and uncertainty to a robust earnings season.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

CEO Alex Karp used the company's earnings call to dismiss his critics, saying, "Enjoy, get some popcorn, they're crying." ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

It pays a semiannual dividend and yields 4.4% based on the two most recent payments. Morningstar Equity analysts note that ...

Kimberly-Clark, the maker of Huggies, said Monday it will acquire Kenvue, Tylenol’s parent, in a cash-and-stock transaction valued at nearly $50 billion. The companies said the combined portfolio will ...